Is 3M’s Resurgence Signaling a Sustainable Recovery?

Strategic Shifts Yield Operational Gains

The industrial conglomerate 3M is demonstrating unexpected strength following years of transformation, with surprisingly robust quarterly earnings and an upgraded annual forecast suggesting its turnaround strategy is gaining traction. The former problem child of the industrial sector now faces the critical question: can this legacy giant genuinely secure a lasting return to growth?

Behind 3M’s recovery lies a profound corporate transformation. The spin-off of its healthcare business, Solventum, in April 2024 created a leaner, more focused industrial entity. Concurrently, the company is systematically working toward complete PFAS chemical phase-out by the end of 2025—a necessary adaptation to evolving regulatory landscapes.